Amsterdam-Sana
The European Medicines Agency announced today that it has begun studying an application to license an anti-coronavirus (Covid 19) pill manufactured by the American pharmaceutical company Pfizer.
AFP quoted the agency as saying that it had begun studying an application for a conditional marketing license for the drug, which bears the name Paxilvid, and that it would assess its benefits and risks within a few weeks, adding that the timing depended on whether Pfizer's data was solid enough.
Last December, the agency approved the emergency use of the treatment known as Baxlovid in the European Union in order to support national authorities that can decide on the possible early use of the drug.
The European Medicines Agency has also issued an emergency use authorization for an anti-coronavirus pill manufactured by Merck and is considering an application by the company for a general license.
Follow Sana's news on Telegram https://t.me/SyrianArabNewsAgency